These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 12094149

  • 1. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V, Cavero I.
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [Abstract] [Full Text] [Related]

  • 2. Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias.
    Cavero I, Mestre M, Guillon JM, Crumb W.
    Expert Opin Pharmacother; 2000 Jul; 1(5):947-73. PubMed ID: 11249502
    [Abstract] [Full Text] [Related]

  • 3. [Ion channels and arrhythmias].
    Borchard U, Hafner D.
    Z Kardiol; 2000 Jul; 89 Suppl 3():6-12. PubMed ID: 10810780
    [Abstract] [Full Text] [Related]

  • 4. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
    Fazekas T, Liszkai G.
    Orv Hetil; 2005 Mar 06; 146(10):451-60. PubMed ID: 15835343
    [Abstract] [Full Text] [Related]

  • 5. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D, Penland RC, stamps A, Traebert M, Dumotier B, Georgiva A, Helmlinger G, Lett GS.
    Prog Biophys Mol Biol; 2006 Mar 06; 90(1-3):414-43. PubMed ID: 16321428
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C, Canceil O, Iaria P.
    Encephale; 2000 Mar 06; 26(6):62-72. PubMed ID: 11217540
    [Abstract] [Full Text] [Related]

  • 8. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.
    Curr Opin Investig Drugs; 2006 Mar 06; 7(3):256-63. PubMed ID: 16555686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V.
    Neuropsychopharmacol Hung; 2004 Mar 06; 6(1):5-12. PubMed ID: 15125308
    [Abstract] [Full Text] [Related]

  • 11. Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studies.
    Shah RR.
    Novartis Found Symp; 2005 Mar 06; 266():251-80; discussion 280-5. PubMed ID: 16050273
    [Abstract] [Full Text] [Related]

  • 12. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K, Dorian P.
    Europace; 2007 Sep 06; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [Abstract] [Full Text] [Related]

  • 13. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V, Cardiac Safety in Schizophrenia Group.
    Encephale; 2002 Sep 06; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of cardiac potassium channels.
    Tamargo J, Caballero R, Gómez R, Valenzuela C, Delpón E.
    Cardiovasc Res; 2004 Apr 01; 62(1):9-33. PubMed ID: 15023549
    [Abstract] [Full Text] [Related]

  • 15. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P, Hreiche R, Turgeon J.
    Can J Cardiol; 2005 Aug 01; 21(10):857-64. PubMed ID: 16107909
    [Abstract] [Full Text] [Related]

  • 16. The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes.
    Liu XK, Katchman A, Ebert SN, Woosley RL.
    J Pharmacol Exp Ther; 1998 Dec 01; 287(3):877-83. PubMed ID: 9864267
    [Abstract] [Full Text] [Related]

  • 17. Gender differences in the proarrhythmic potential of QT-prolonging drugs.
    Wolbrette D.
    Curr Womens Health Rep; 2002 Apr 01; 2(2):105-9. PubMed ID: 12116598
    [Abstract] [Full Text] [Related]

  • 18. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
    Riera AR, Uchida AH, Ferreira C, Ferreira Filho C, Schapachnik E, Dubner S, Zhang L, Moffa PJ.
    Cardiol J; 2008 Apr 01; 15(3):209-19. PubMed ID: 18651412
    [Abstract] [Full Text] [Related]

  • 19. QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.
    Testai L, Breschi MC, Martinotti E, Calderone V.
    J Appl Toxicol; 2007 Apr 01; 27(3):270-5. PubMed ID: 17265420
    [Abstract] [Full Text] [Related]

  • 20. Drug-induced q-T prolongation.
    Kao LW, Furbee RB.
    Med Clin North Am; 2005 Nov 01; 89(6):1125-44, x. PubMed ID: 16227057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.